Cargando…

Characterization of Mesothelin Glycosylation in Pancreatic Cancer: Decreased Core Fucosylated Glycoforms in Pancreatic Cancer Patients’ Sera

Currently, there are no reliable biomarkers for the diagnosis of pancreatic cancer (PaC). Glycoproteomic approaches that analyze the glycan determinants on specific glycoproteins have proven useful to develop more specific cancer biomarkers than the corresponding protein levels. In PaC, mesothelin (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Duran, Adrià, Guerrero, Pedro E., Ortiz, Maria Rosa, Pérez del Campo, Dúnia, Castro, Ernesto, Garcia-Velasco, Adelaida, Fort, Esther, de Llorens, Rafael, Saldova, Radka, Llop, Esther, Peracaula, Rosa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405996/ https://www.ncbi.nlm.nih.gov/pubmed/36009489 http://dx.doi.org/10.3390/biomedicines10081942

Ejemplares similares

Characterisation of the main PSA glycoforms in aggressive prostate cancer
por: Gratacós-Mulleras, Anna, et al.
Publicado: (2020)

Improvement of Prostate Cancer Diagnosis by Detecting PSA Glycosylation-Specific Changes
por: Llop, Esther, et al.
Publicado: (2016)

Improvement of Prostate Cancer Diagnosis by Detecting PSA Glycosylation-Specific Changes: Erratum
por: Llop, Esther, et al.
Publicado: (2018)

Glycoprotein biomarkers for the detection of pancreatic ductal adenocarcinoma
por: Llop, Esther, et al.
Publicado: (2018)

5-AZA-dC induces epigenetic changes associated with modified glycosylation of secreted glycoproteins and increased EMT and migration in chemo-sensitive cancer cells
por: Greville, Gordon, et al.
Publicado: (2021)

Improved Pancreatic Adenocarcinoma Diagnosis in Jaundiced and Non-Jaundiced Pancreatic Adenocarcinoma Patients through the Combination of Routine Clinical Markers Associated to Pancreatic Adenocarcinoma Pathophysiology
por: Ferri, María José, et al.
Publicado: (2016)

Hypoxia Alters Epigenetic and N-Glycosylation Profiles of Ovarian and Breast Cancer Cell Lines in-vitro
por: Greville, Gordon, et al.
Publicado: (2020)

Knockdown of α2,3-Sialyltransferases Impairs Pancreatic Cancer Cell Migration, Invasion and E-selectin-Dependent Adhesion
por: Guerrero, Pedro Enrique, et al.
Publicado: (2020)

Altered Glycosylation in Tumours Focused to Cancer Diagnosis
por: Peracaula, Rosa, et al.
Publicado: (2008)

Overexpression of Mesothelin in Pancreatic Ductal Adenocarcinoma (PDAC)
por: Le, Kai, et al.
Publicado: (2020)

Comparative Study of Blood-Based Biomarkers, α2,3-Sialic Acid PSA and PHI, for High-Risk Prostate Cancer Detection
por: Ferrer-Batallé, Montserrat, et al.
Publicado: (2017)

Elevated levels of abnormally-fucosylated haptoglobins in cancer sera.
por: Thompson, S., et al.
Publicado: (1987)

Characterization of human mesothelin transcripts in ovarian and pancreatic cancer
por: Muminova, Zhanat E, et al.
Publicado: (2004)

Low serum mesothelin in pancreatic cancer patients results from retention of shed mesothelin in the tumor microenvironment
por: Zhang, Xianyu, et al.
Publicado: (2022)

Sialyltransferase Inhibitor Ac(5)3F(ax)Neu5Ac Reverts the Malignant Phenotype of Pancreatic Cancer Cells, and Reduces Tumor Volume and Favors T-Cell Infiltrates in Mice
por: Miró, Laura, et al.
Publicado: (2022)

Global serum glycoform profiling for the investigation of dystroglycanopathies & Congenital Disorders of Glycosylation
por: Heywood, Wendy E., et al.
Publicado: (2016)

Development of improved therapeutic mesothelin-based vaccines for pancreatic cancer
por: White, Michael, et al.
Publicado: (2018)

Pancreatic Cancer Cell Glycosylation Regulates Cell Adhesion and Invasion through the Modulation of α2β1 Integrin and E-Cadherin Function
por: Bassagañas, Sònia, et al.
Publicado: (2014)

Chemical synthesis of erythropoietin glycoforms for insights into the relationship between glycosylation pattern and bioactivity
por: Murakami, Masumi, et al.
Publicado: (2016)

Methylation-Associated Partial Down-Regulation of Mesothelin Causes Resistance to Anti-Mesothelin Immunotoxins in a Pancreatic Cancer Cell Line
por: Hollevoet, Kevin, et al.
Publicado: (2015)

Differential Expression and Diagnostic Value of MUC5AC Glycoforms in Pancreatic Ductal Adenocarcinoma
por: Manne, Ashish, et al.
Publicado: (2023)

Identification and Relative Quantification of hFSH Glycoforms in Women’s Sera via MS–PRM-Based Approach
por: Melchiorre, Chiara, et al.
Publicado: (2021)

Towards Controlling the Glycoform: A Model Framework Linking Extracellular Metabolites to Antibody Glycosylation
por: Jedrzejewski, Philip M., et al.
Publicado: (2014)

Histoepigenetic analysis of the mesothelin network within pancreatic ductal adenocarcinoma cells reveals regulation of retinoic acid receptor gamma and AKT by mesothelin
por: Lurie, Eugene, et al.
Publicado: (2020)

Fucosylation and protein glycosylation create functional receptors for cholera toxin
por: Wands, Amberlyn M, et al.
Publicado: (2015)

Exploring the Glycosylation of Serum CA125
por: Saldova, Radka, et al.
Publicado: (2013)

Mesothelin blockage by Amatuximab suppresses cell invasiveness, enhances gemcitabine sensitivity and regulates cancer cell stemness in mesothelin-positive pancreatic cancer cells
por: Matsuzawa, Fumihiko, et al.
Publicado: (2021)

Glycosylation Changes on Serum Glycoproteins in Ovarian Cancer May Contribute to Disease Pathogenesis
por: Saldova, Radka, et al.
Publicado: (2008)

α2,3-Sialyltransferase ST3Gal III Modulates Pancreatic Cancer Cell Motility and Adhesion In Vitro and Enhances Its Metastatic Potential In Vivo
por: Pérez-Garay, Marta, et al.
Publicado: (2010)

Eradicating mesothelin-positive human gastric and pancreatic tumors in xenograft models with optimized anti-mesothelin antibody–drug conjugates from synthetic antibody libraries
por: Hsu, Hung-Ju, et al.
Publicado: (2021)

From Malignant Progression to Therapeutic Targeting: Current Insights of Mesothelin in Pancreatic Ductal Adenocarcinoma
por: Montemagno, Christopher, et al.
Publicado: (2020)

The glycosylation landscape of pancreatic cancer
por: Munkley, Jennifer
Publicado: (2019)

Murine mesothelin: characterization, expression, and inhibition of tumor growth in a murine model of pancreatic cancer
por: Zervos, Emmanuel, et al.
Publicado: (2016)

Abnormal N‐glycan fucosylation, galactosylation, and sialylation of IgG in adults with classical galactosemia, influence of dietary galactose intake
por: Treacy, Eileen P., et al.
Publicado: (2021)

The anti-mesothelin monoclonal antibody amatuximab enhances the anti-tumor effect of gemcitabine against mesothelin-high expressing pancreatic cancer cells in a peritoneal metastasis mouse model
por: Mizukami, Tatsuzo, et al.
Publicado: (2018)

A Novel Survival-Based Tissue Microarray of Pancreatic Cancer Validates MUC1 and Mesothelin as Biomarkers
por: Winter, Jordan M., et al.
Publicado: (2012)

Expansion of Anti-Mesothelin Specific CD4(+) and CD8(+) T Cell Responses in Patients with Pancreatic Carcinoma
por: Chen, Yuan, et al.
Publicado: (2014)

Efficient growth suppression in pancreatic cancer PDX model by fully human anti-mesothelin CAR-T cells
por: Jiang, Hua, et al.
Publicado: (2017)

Glycosylation Effects on FSH-FSHR Interaction Dynamics: A Case Study of Different FSH Glycoforms by Molecular Dynamics Simulations
por: Meher, Biswa Ranjan, et al.
Publicado: (2015)

Influence of N-glycosylation on effector functions and thermal stability of glycoengineered IgG1 monoclonal antibody with homogeneous glycoforms
por: Wada, Ryuta, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_mluh0o72ou9qar6rohtil84u5l